Chrysos Corporation (ASX:C79) has disclosed unaudited total revenue of $36.7 million for the four months from July to October 2026, representing 27% growth versus the prior corresponding period, as the company's global PhotonAssay™ fleet reached 51 deployed units.

Key Points

  • Unaudited total revenue of $36.7 million for July to October 2026, comprising $22.6 million MMAP revenue and $13.7 million AAC revenue
  • PhotonAssay™ samples analysed reached 4.91 million for the four-month period, up 43% versus the prior corresponding period
  • Funding position of $139.5 million as at 31 October 2026, including $19.5 million cash and $120 million in undrawn debt
  • 15 new lease agreements signed in FY27, bringing total contracted units to 97, with six units deployed year-to-date and six units currently deploying

Revenue and Sample Volume Performance to 31 October 2026

According to the filing, unaudited total revenue for the four months to 31 October 2026 was $36.7 million, with MMAP revenue of $22.6 million representing 7% growth on the prior corresponding period and additional assay charge (AAC) revenue of $13.7 million representing 79% growth on the prior corresponding period. AAC revenue now represents 38% of PhotonAssay™ revenue, compared with 26% for the four months to 31 October 2025. October samples processed totalled 1.36 million, up 48% on the prior corresponding period. Monthly throughput grew consistently between 36% and 48% in FY27 year-to-date, with volumes exceeding one million samples every month since March 2026.

Fleet Deployments and Contracted Units as at 19 November 2026

The filing states the global PhotonAssay™ fleet stood at 51 deployed units as at 19 November 2026, net of the decommissioning of MSA's Bamako unit in Mali. Six units were deployed year-to-date in FY27, including sites in Kalgoorlie Australia, Rouyn Noranda Canada, Surrey Canada, Mt Ida Gold Mine Australia, Paramaribo Suriname, and Korhogo Ivory Coast. Six units are currently being deployed at sites including Ahafo Ghana, Merian Suriname, Cononish Gold Mine Scotland, Addi Baba Morocco, Sodankyla Finland, and West Red Lake Canada. Total contracted units reached 97, net of one MSA unit cancelled since 30 June 2026 and replaced with the Paramaribo unit.

Funding Position and Manufacturing Cadence

The filing disclosed a funding position of $139.5 million as at 31 October 2026, comprising $19.5 million in cash and $120 million in undrawn debt. The company described itself as operating cash-flow positive and stated the funding position supports an increased manufacturing cadence of PhotonAssay™ units. Since the August 2026 results, seven units have been manufactured, taking the total manufactured figure from 59 to 66. Total contracted units increased by 10 from 87 to 97 over the same period. The 15 new lease agreements signed in FY27 included four direct-to-miner agreements, four units with SGS, two with BV, four with ALS, and one with Alfred H Knight.